Alfasigma, headquartered in Bologna, Italy, is a global pharmaceutical company whose roots date back to 1948. Through its CDMO business division Morpho, the company offers a comprehensive suite of services, with a particular focus on sterile fill/finish capabilities for injectable and oral formulations. Alfasigma leverages its innovative, cutting-edge technologies and decades of expertise to support pharmaceutical and biotech clients from development through commercial production.